These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1555659)

  • 1. Slow, tight binding to human renin of some nonpeptidic renin inhibitors containing a 4-methoxymethoxypiperidinylamide at the P4 position.
    Stein HH; Fung AK; Cohen J; Baker WR; Rosenberg SH; Boyd SA; Dayton BD; Armiger YL; Condon SL; Mantei RA
    FEBS Lett; 1992 Apr; 300(3):301-4. PubMed ID: 1555659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of benzimidazole derivatives as orally active renin inhibitors: Optimization of 3,5-disubstituted piperidine to improve pharmacokinetic profile.
    Tokuhara H; Imaeda Y; Fukase Y; Iwanaga K; Taya N; Watanabe K; Kanagawa R; Matsuda K; Kajimoto Y; Kusumoto K; Kondo M; Snell G; Behnke CA; Kuroita T
    Bioorg Med Chem; 2018 Jul; 26(12):3261-3286. PubMed ID: 29754833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of orally bioavailable alkyl amine renin inhibitors.
    Xu Z; Cacatian S; Yuan J; Simpson RD; Jia L; Zhao W; Tice CM; Flaherty PT; Guo J; Ishchenko A; Singh SB; Wu Z; McKeever BM; Scott BB; Bukhtiyarov Y; Berbaum J; Mason J; Panemangalore R; Cappiello MG; Bentley R; Doe CP; Harrison RK; McGeehan GM; Dillard LW; Baldwin JJ; Claremon DA
    Bioorg Med Chem Lett; 2010 Jan; 20(2):694-9. PubMed ID: 19959358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of tertiary alcohol-bearing piperidines.
    Chen A; Cauchon E; Chefson A; Dolman S; Ducharme Y; Dubé D; Falgueyret JP; Fournier PA; Gagné S; Gallant M; Grimm E; Han Y; Houle R; Huang JQ; Hughes G; Jûteau H; Lacombe P; Lauzon S; Lévesque JF; Liu S; Macdonald D; Mackay B; McKay D; Percival MD; St-Jacques R; Toulmond S
    Bioorg Med Chem Lett; 2011 Jul; 21(13):3976-81. PubMed ID: 21641209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substituted piperidines--highly potent renin inhibitors due to induced fit adaptation of the active site.
    Vieira E; Binggeli A; Breu V; Bur D; Fischli W; Güller R; Hirth G; Märki HP; Müller M; Oefner C; Scalone M; Stadler H; Wilhelm M; Wostl W
    Bioorg Med Chem Lett; 1999 May; 9(10):1397-402. PubMed ID: 10360744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and optimization of new piperidines as renin inhibitors.
    Corminboeuf O; Bezençon O; Grisostomi C; Remeň L; Richard-Bildstein S; Bur D; Prade L; Hess P; Strickner P; Fischli W; Steiner B; Treiber A
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6286-90. PubMed ID: 20843686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and preparation of potent, nonpeptidic, bioavailable renin inhibitors.
    Bezençon O; Bur D; Weller T; Richard-Bildstein S; Remen L; Sifferlen T; Corminboeuf O; Grisostomi C; Boss C; Prade L; Delahaye S; Treiber A; Strickner P; Binkert C; Hess P; Steiner B; Fischli W
    J Med Chem; 2009 Jun; 52(12):3689-702. PubMed ID: 19358611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piperidine-based renin inhibitors: upper chain optimization.
    Corminboeuf O; Bezençon O; Remeň L; Grisostomi C; Richard-Bildstein S; Bur D; Prade L; Strickner P; Hess P; Fischli W; Steiner B; Treiber A
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6291-6. PubMed ID: 20843690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and discovery of new (3S,5R)-5-[4-(2-chlorophenyl)-2,2-dimethyl-5-oxopiperazin-1-yl]piperidine-3-carboxamides as potent renin inhibitors.
    Mori Y; Ogawa Y; Mochizuki A; Nakamura Y; Sugita C; Miyazaki S; Tamaki K; Matsui Y; Takahashi M; Nagayama T; Nagai Y; Inoue S; Nishi T
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7677-82. PubMed ID: 23122821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of spirocyclic piperidines.
    Chen A; Aspiotis R; Campeau LC; Cauchon E; Chefson A; Ducharme Y; Falgueyret JP; Gagné S; Han Y; Houle R; Laliberté S; Larouche G; Lévesque JF; McKay D; Percival D
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7399-404. PubMed ID: 22071301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and optimization of novel (3S,5R)-5-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)piperidine-3-carboxamides as orally active renin inhibitors.
    Mori Y; Ogawa Y; Mochizuki A; Nakamura Y; Fujimoto T; Sugita C; Miyazaki S; Tamaki K; Nagayama T; Nagai Y; Inoue S; Chiba K; Nishi T
    Bioorg Med Chem; 2013 Sep; 21(18):5907-22. PubMed ID: 23886807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A practical synthesis of renin inhibitor MK-1597 (ACT-178882) via catalytic enantioselective hydrogenation and epimerization of piperidine intermediate.
    Molinaro C; Shultz S; Roy A; Lau S; Trinh T; Angelaud R; O'Shea PD; Abele S; Cameron M; Corley E; Funel JA; Steinhuebel D; Weisel M; Krska S
    J Org Chem; 2011 Feb; 76(4):1062-71. PubMed ID: 21250716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of renin inhibitors: incorporation of transition-state isostere side chains that span from the S1 to the S3 binding pockets and examination of P3-modified renin inhibitors.
    Plummer MS; Shahripour A; Kaltenbronn JS; Lunney EA; Steinbaugh BA; Hamby JM; Hamilton HW; Sawyer TK; Humblet C; Doherty AM
    J Med Chem; 1995 Jul; 38(15):2893-905. PubMed ID: 7636850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin inhibitor SC-51106 complexed with human renin: discovery of a new binding site adjacent to P3.
    Hanson GJ; Clare M; Summers NL; Lim LW; Neidhart DJ; Shieh HS; Stevens AM
    Bioorg Med Chem; 1994 Sep; 2(9):909-18. PubMed ID: 7712126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of passive permeability and gut efflux transport on the oral bioavailability of novel series of piperidine-based renin inhibitors in rodents.
    Lévesque JF; Bleasby K; Chefson A; Chen A; Dubé D; Ducharme Y; Fournier PA; Gagné S; Gallant M; Grimm E; Hafey M; Han Y; Houle R; Lacombe P; Laliberté S; MacDonald D; Mackay B; Papp R; Tschirret-Guth R
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5547-51. PubMed ID: 21784634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The discovery and preparation of disubstituted novel amino-aryl-piperidine-based renin inhibitors.
    Cody WL; Holsworth DD; Powell NA; Jalaie M; Zhang E; Wang W; Samas B; Bryant J; Ostroski R; Ryan MJ; Edmunds JJ
    Bioorg Med Chem; 2005 Jan; 13(1):59-68. PubMed ID: 15582452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of pyridone-substituted piperidines.
    Chen A; Campeau LC; Cauchon E; Chefson A; Ducharme Y; Dubé D; Falgueyret JP; Fournier PA; Gagné S; Grimm E; Han Y; Houle R; Huang JQ; Lacombe P; Laliberté S; Lévesque JF; Liu S; MacDonald D; Mackay B; McKay D; Percival MD; Regan C; Regan H; St-Jacques R; Toulmond S
    Bioorg Med Chem Lett; 2011 Jul; 21(13):3970-5. PubMed ID: 21621998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Models for the three-dimensional structure of renin inhibitors bound in the active site of human renin: an analysis of the properties that produce tight binding.
    Carlson WD; Handschumacher M; Summers N; Karplus M; Haber E
    J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S91-3. PubMed ID: 2485071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of renin inhibitors containing a simple aspartate binding moiety that imparts reduced P450 inhibition.
    Lawhorn BG; Tran T; Hong VS; Morgan LA; Le BT; Harpel MR; Jolivette L; Diaz E; Schwartz B; Gross JW; Tomaszek T; Semus S; Concha N; Smallwood A; Holt DA; Kallander LS
    Bioorg Med Chem Lett; 2017 Nov; 27(21):4838-4843. PubMed ID: 28985999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel class of oral direct renin inhibitors: highly potent 3,5-disubstituted piperidines bearing a tricyclic p3-p1 pharmacophore.
    Ostermann N; Ruedisser S; Ehrhardt C; Breitenstein W; Marzinzik A; Jacoby E; Vangrevelinghe E; Ottl J; Klumpp M; Hartwieg JC; Cumin F; Hassiepen U; Trappe J; Sedrani R; Geisse S; Gerhartz B; Richert P; Francotte E; Wagner T; Krömer M; Kosaka T; Webb RL; Rigel DF; Maibaum J; Baeschlin DK
    J Med Chem; 2013 Mar; 56(6):2196-206. PubMed ID: 23360239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.